Carb-X

Workshop on Generation and Measurement of Vaccine Durability
2022-07-27 12:00 - 2022-07-28 14:30 (America/New_York) | VIRTUAL EVENT
Workshop objectives are to 1) review knowledge about vaccine durability; 2) identify factors contributing to vaccine durability; 3) explore assays and markers to measure vaccine durability in people; and 4) identify gaps in the knowledge about vaccine durability requiring further research or funding. NIAID program staff are organizing this workshop along with external experts in vaccinology and immunology.

CFRI’s 35th Virtual National CF Education Conference: Focus on the Future
2022-07-29 08:00 - 2022-07-31 17:00 (America/New_York)
The Cystic Fibrosis Research Institute is holding its 35th Virtual National CF Education Conference this year from July 29-31, 2022. The conference, with a theme of “Focus on the Future,” brings together the national and international Cystic Fibrosis community for a virtual weekend of content and connection. Nationally-renowned presenters will address subjects that are vital to the CF community.

Hear from CFRI-funded researchers on innovative CF research, visit pharmaceutical & medical technology exhibits, and attend support groups and workshops. Socialize with members of the global CF community and honor CF heroes at an inspirational awards ceremony.

The 19th International Symposium on Staphylococci and Staphylococcal Infections
2022-08-28 - 2022-08-31 | Perth Convention and Exhibition Centre (PCEC), 21 Mounts Bay Rd, Perth, WA, 6000, Australia
It is a pleasure to invite you to participate in the 19th International Symposium on Staphylococci and Staphylococcal Infections, which will be held on 28 – 31 August 2022 in Perth, Australia.
ISSSI 2022 will cover many interdisciplinary subjects regarding staphylococci and staphylococcal infections. Sessions will be presented by the world’s leading experts in each of the research fields. Oral and poster sessions will be an integral part of the program as well, and all delegates are invited to submit abstracts. To promote discussion and interaction between delegates and the invited speakers, the meeting’s registration includes the welcome reception, lunches and morning and afternoon teas.
ISSSI 2022 will be held at the Perth Convention and Exhibition Centre located in the heart of the city. World class public transport, hotels and internationally acclaimed bars and restaurants are all within walking distance from the Centre. The Perth international and domestic airport terminals are only a short transit to the city and are serviced by numerous daily direct flights from Asia and Europe.
We are confident that you will find the symposium’s programme both scientifically stimulating and informative and we look forward to meeting you in Perth.
Click here to learn more.
Click here to view the agenda.
Click here to register.

World AMR Congress 2022
2022-09-07 08:00 - 2022-09-08 17:00 (America/New_York) | Gaylord National Resort & Convention Center, National Harbor, MD, United States
Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance.
Join us for the World AMR Congress and get full access to the Disease Prevention & Control Summit co-located at the Gaylord National Resort & Convention Center on September 7-8.

Center for Pathogen Research & Training Open Webinar ft. Professor Outterson
2022-09-14 15:30 - 16:30 (America/New_York)
Professor Kevin Outterson, J.D., LL.M, Executive Director, CARB-X will be speaking on the topic of “Repairing the broken business model for antimicrobial R&D”
Wednesday, September 14, 2022, 3:30 p.m.
Zoom ID: 953 7011 3908

ESCMID/ASM Conference on Drug Development
2022-10-04 08:00 - 2022-10-07 17:00 (America/New_York)
The 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place in Dublin, Ireland on October 4-7, 2022. Make sure to save the date.
Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance.
Dr. Erin Duffy, CARB-X Chief of R&D, will be presenting on preclinical development of non-traditional/novel classes during Symposium 7.

The Broken Pipeline of Antibiotics and Ongoing Efforts to Fix It
2022-10-10 19:00 - 20:30 (Africa/Nairobi)
This webinar has been prepared in collaboration with CARB-X, a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria, a leading cause of death around the world.
The webinar is part of the AMR Ambassadors Program open webinars and aims at educating us about the complex process behind antibiotic/diagnostics research, development and approval, challenges associated with it, and the negative implications. This will help us value the antibiotics already approved for use, and hopefully encourage us to educate others to appreciate these antibiotics, and actively take part in their conversation.
We will be inspired to support ongoing efforts, develop creative interventions in our own small ways, and hopefully trigger the interest of tertiary level students and early career professionals to pursue a further education or a career in drug discovery, and development.
Dr. Erin Duffy will be the keynote speaker for this webinar.

World Vaccine Congress | Europe
2022-10-11 08:00 - 2022-10-14 17:00 (America/New_York) | Palau de Congressos de Barcelona
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe.
Now in its 23rd year the World Vaccine Congress Europe and co-located events, Veterinary Vaccine and Immuno-Oncology congresses will continue to bring experts from the whole value chain under one roof.
Influenza & Respiratory • Emerging & Re-emerging • Clinical Trials • Bioprocessing & Manufacturing • Technology • Antimicrobial Resistance • Partnerships

AMR: Science, Society, Commercialization and Policy
2022-10-12 08:00 - 17:00 (America/New_York)
The solution to the AMR problem lies as much with disciplines outside of biomedicine as within it. Thus, a major goal of the AMR Task Force is to engage and connect those working outside the biomedical sciences, with those working within it. With strong Business and Engineering schools, thriving Social Science and Humanities Faculties, and renowned Science and Health Science Faculties, we are eager to build on McMaster’s strong history of interdisciplinary collaboration, and catalyze university-wide AMR research under the auspices of Global Nexus.
This one-day symposium aims to promote action within the McMaster community around themes including scientific, economic and societal issues related to AMR. The day will include a morning symposium where internationally acclaimed thought leaders will speak broadly to these themes, followed by afternoon workshops focused on brainstorming opportunities and hurdles associated with addressing key issues, and ideas for future conversations and collaborations.
Speakers include Ayush Kumar, a professor of microbiology at the University of Manitoba; Christine Årdal, a senior advisor at the Institute of Public Health in Norway; Kevin Outterson, a professor of law at Boston University and the executive director of CARB-X; and Muhammad H. Zaman, a professor of biomedical engineering at Boston University.

INTO CLINICAL PRACTICE: MEETING THE CHALLENGES OF GRAM-NEGATIVE INFECTION MANAGEMENT
2022-10-12 09:00 - 17:00 (Europe/London) | VIRTUAL EVENT
This virtual conference will explore the current challenges and treatment opportunities for Gram-negative infections. Delegates will, through plenary lectures and debate, learn about clinical presentations of Gram-negatives and the latest in research and development.
Dr. Erin Duffy will be a featured presenter during session seven: What Does the Future Look Like? Improving Gram-Negative Treatments.

Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance - A Workshop
2022-10-13 08:00 - 2022-10-14 17:00 (America/New_York)
On October 13-14, 2022, the Forum on Drug Discovery, Development, and Translation, the Forum on Medical and Public Health Preparedness for Disasters and Emergencies, and the Forum on Microbial Threats will host a public workshop for stakeholders to discuss the current landscape of rapid point-of-care diagnostics to address antibiotic resistance, consider challenges and opportunities for spurring innovation, and discuss practical next steps for accelerating the development of new diagnostic tools.
Background
The use and misuse of antibiotics contributes to the rise in drug-resistant bacteria – a serious and worsening threat to human health. Addressing the problem of antibiotic resistance requires measures to spur innovation and ensure the prudent use of existing drugs. Rapid point-of-care diagnostics can play an important role in avoiding unnecessary use of antimicrobials by providing clinicians with the right information at the right time to help them make decisions about appropriate drug treatment for patients. Diagnostics also have the capacity to support early detection and diagnosis of drug-resistant bacterial infections, enable disease surveillance, and help prevent disease spread.
The public workshop will feature invited presentations and discussions to:

Examine the current state of rapid diagnostic development, including examples of successes and limitations of current approaches.
Consider the unique challenges for the development and use/uptake of rapid diagnostics in health care settings (e.g., feasibility of clinical utility studies)
Consider gaps that rapid diagnostics may be best-suited to address (e.g. tools to support targeted treatment decisions in the healthcare setting, tools to enable real-time surveillance based on routine hospital data).
Discuss practical short- and long-term opportunities for spurring the development of new diagnostics that can help address antibiotic resistance.

Planning Committee
Kent E. Kester (co-chair), International AIDS Vaccine Initiative
Betsy Wonderly Trainor (co-chair), CARB-X
John Billington, GSK
Carey-Ann Burnham, Washington University School of Medicine in St. Louis
Paul Eder, National Institute of Allergy and Infectious Diseases, NIH
Deborah Hung, Harvard Medical School
Amanda Jezek, Infectious Diseases Society of America
Robin Patel, Mayo Clinic
Ribhi Shawar, Center for Devices and Radiological Health, FDA
Susan Van Meter, The American Clinical Laboratory Association

Interdisciplinary Course on Antibiotics and Resistance ICARe
2022-10-15 08:00 - 2022-10-23 17:00 (America/New_York)
The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined.

World Health Summit 2022
2022-10-16 08:00 - 2022-10-18 17:00 (America/New_York)
3 DAYS – 100+ NATIONS – 400+ SPEAKERS – 6,000+ PARTICIPANTS
HEALTH FOR ALL IS THE GOAL – WHS 2022 IS THE EVENT
#WHS2022 – where science, politics, the private sector and civil society meet for inspiring talks, enhanced cooperations and new solutions.

The World Health Summit strengthens exchange, stimulates innovative solutions to health challenges, fosters global health as a key political issue and promotes the global health debate in the spirit of the UN Sustainable Development Goals: SDG 17 “Partnership for the Goals”.
WHS 2022 will focus on “Making the Choice for Health” by reflecting on the most pressing topics, including:

Investment for Health and Well-Being
Climate Change and Planetary Health
Architecture for Pandemic Preparedness
Digital Transformation for Health
Food Systems and Health
Health Systems Resilience and Equity
Global Health for Peace

Read more about the first joint World Health Summit with WHO

Infectious Diseases Week 2022
2022-10-19 08:00 - 2022-10-23 17:00 (America/New_York) | London, UK
ID Week Learning Objectives:
Update infectious diseases clinicians, investigators, infection preventionists, and pharmacists with state of- the-art developments in the field, including timely reviews of recent advances in clinical care and research, and original reports of clinical, translational, and basic research in infectious diseases and healthcare epidemiology.
Bridge the widening gaps among the fields of infectious diseases clinical practice and research, including clinical, epidemiological, health services, implementation, translational and basic research.
Promote multi-disciplinary dialogue and collaboration among clinicians, investigators and pharmacists, thus facilitating advances in the prevention, diagnosis and treatment of infectious diseases.
Provide training in skills that promote the Infectious Disease specialty, including medical education, leadership and advocacy for policies that impact infectious diseases practice and the healthcare team.

2022 Drug Discovery & Development Centre (H3D) Symposium: Celebrating a Decade of Infectious Diseases Drug Discovery and Development in Africa
2022-10-25 - 2022-10-28 | Spier Hotel and Conference Centre, Stellenbosch, South Africa
COVID Update: We are less than 8 weeks away from the H3D 2021 Symposium which was scheduled for 10th – 12th March 2021. Unfortunately, I regret to announce that our organizing committee has decided to cancel the H3D 2021 Symposium, which was in fact a rescheduled version of the original H3D 2020 symposium. As all of us are aware, the COVID-19 outbreak continues to pose serious transmission risks for all face-to-face interactions, particularly with large international events like this symposium. In addition to the transmission risk, navigating changing regulations with regards to international travel and gatherings is quite daunting to all. Given the risks and uncertainty, I hope that you will understand the reasoning for the cancellation.
However, I am pleased to inform you that we will be hosting a new H3D symposium from 25th-28th Oct 2022 at the same venue, Spier Wine Estate in Stellenbosch outside of Cape Town, South Africa. We hope you will consider joining us then.
Welcome from Kelly Chibale, Chair of the 2020 H3D Symposium Committee:
I would like to extend an invitation to you to attend the 2021 Symposium hosted by the Drug Discovery & Development Centre (H3D). This will be the 4th H3D Symposium to be held in Africa (the 3rd in the Western Cape) and is a very special Symposium as it marks the 10th anniversary of the launch of H3D. Thus, the theme of this special H3D symposium was derived as ‘Celebrating a Decade of Infectious Diseases Drug Discovery and Development’. The Symposium will cover the Centre’s research over 10 years conducted on Malaria, Tuberculosis (TB), Neglected Tropical Diseases (NTDs) and drug resistant infections of bacterial origin towards combating AntiMicrobial Resistance (AMR).
The Symposium takes place in true Cape style at the Spier Hotel, surrounded by leafy vineyards and beautiful mountain scenery and situated on the outskirts of the historic and picturesque old town of Stellenbosch. The organizing committee is currently encouraging participation in the symposium by drug discovery scientists from Africa, as well from all over the globe, who are working on the discovery of drugs to combat TB, Malaria, AMR and a host of NTDs. Through this symposium, we aim to ensure that all these highly infectious, deleterious diseases that primarily affect the African population, will receive worldwide attention in both scientific and non-scientific arenas.
I urge you to consider participating and making the most of this opportunity. Besides networking with the other delegates, there will be wonderful scenery to admire and activities to enjoy. I hope that participation in this symposium will inspire your further research for the next decade!
CARB-X participants include Erin Duffy, Chief of R&D.
Click here to learn more.
Click here to view the agenda.
Click here to register.

Fundamentals of in vitro diagnostic product development: Making the move from academic and entrepreneurial R&D to product development webinar series
2022-11-07 08:00 - 2022-12-09 17:00 (America/New_York)
Are you an India-based academic, R&D manager or scientist interested in transitioning your #AMR #bacterial #diagnostic into an IVD product?
🖥️ Register for the 5-part seminar series from November 7 through December 9.
Topics include:
*️ (11 Nov.) Product development process
*️ (18 Nov.) Design controls
*️ (21 Nov.) Real-life stories: Academia to commercialization
*️ (2 Dec.) Quality management and good laboratory practices
*️ (9 Dec.) Case study: Why the fundamentals matter
Q&A Panelists:
*️ Taslimarif Saiyed, Director and CEO, C-CAMP
*️ Rangarajan Sampath, Senior Vice President and Head, Center for Innovation in Diagnostics, Siemens Healthineers
*️ Tara deBoer, Chief Executive Officer, BioAmp Diagnostics
*️ Debkishore Mitra, Chief Technology Officer and co-founder, Lucira Health
*️ Chandrasekhar Nair, Director, Molbio Diagnostics
*️ Peter J. Dailey, Senior Technical Officer, FIND
Moderated by Betsy Wonderly Trainor, Diagnostics Alliance Director, CARB-X
47% of the global population does not have access to basic diagnostics. To increase access where the global AMR burden is most acute (see fig. 2), CARB-X is partnering with FIND and C-CAMP to support the diagnostic product development ecosystem in India.

BARDA Industry Day 2022
2022-11-15 08:00 - 2022-11-16 17:00 (America/New_York) | Virtual
The Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR), invites you to participate in our annual conference to learn about U.S. Government medical countermeasure priorities, interact with the BARDA and ASPR teams, and network with public and private sector colleagues.
For more information regarding the above offices, and their missions, please visit the following links: BARDA, ASPR, and HHS.
This year’s lineup will have an assortment of BARDA program briefings, featured speakers, special sessions, and breakout sessions addressing our efforts towards our four strategic goals of enhancing preparedness, response, and partnerships against future threats. There will be a renewed focus on strengthening connections, networking, and collaboration within our virtual event environment.
Stay in the loop for BID 2022 announcements and details by following BARDA on Twitter, LinkedIn and Instagram and visiting our website.
We look forward to seeing you online on November 15-16, 2022!

9th Nikkei FT Communicable Diseases Conference
2022-11-15 08:00 - 2022-11-16 17:00 (America/New_York)
The outbreak of COVID-19 has not only revealed Japan’s lag in such areas including R&D of domestic vaccines and medicines, digitalization of its medical systems, and crisis management system itself, but also revealed the vulnerability in the global health system. Developing countries are also confronted with infection controls, which results in virus mutation and spread malaria, tuberculosis, and many other emerging and re-emerging communicable diseases.
Nikkei Inc. has been organizing the annual Nikkei FT Communicable Diseases Conference since 2014, gathering internationally renowned experts in the field; representatives of the private sector, academia and high-ranking government officials responsible for health, both within and outside Japan.
The 9th Conference is to be held on 15th -16th November, discussing how the global health communities should fight against communicable diseases, and how Japan can maximize its contribution. Through Nikkei group’s diverse media network, the concrete and practical action plans that had been proposed from the conference will be disseminated globally.

3rd Global High-Level Ministerial Conference on AMR
2022-11-24 08:00 - 2022-11-25 17:00 (America/New_York) | Muscat, Sultanate of Oman
The Sultanate of Oman is hosting the 3rd High-level Ministerial Conference on Antimicrobial Resistance (AMR) in Muscat, Oman on 24 and 25 November 2022 to accelerate tackling AMR at the national, regional, and global levels and to enhance international cooperation. It will build on the success of the two previous High-level Ministerial Conferences held in the Netherlands in 2014 and 2019. High-level participation will include ministers of health, agriculture, animal health, the environment, and finance, as well as policymakers, key global experts, and representatives from the private sector, civil society, research institutions, and multilateral organizations. The conference will be conducted through keynote speeches, case studies to demonstrate best practices, and interactive discussions between participants. The conference will be an opportunity for an interactive dialogue on One Health action to address the AMR pandemic.
The Third Global High-level Ministerial Conference on Antimicrobial Resistance will center on the theme of paving the way to bold and specific political commitments in the United Nations General Assembly High Level Meeting on AMR (UNGA HLM) in 2024. It is the intention of the Government of Oman that the expected outcomes of the Conference, including the content of the Manifesto, will inform the upcoming UNGA HLM in 2024.

MassBio Innovation Week
2022-12-06 08:00 - 17:00 (America/New_York)
Join us for our first ever Innovation Week! Each day of Innovation Week we will showcase emerging companies or academic research that could have a transformational impact on all patients. Our goal is to use our global platform to connect these changemakers to an audience of prospective partners, investors, stakeholders, and other ecosystem leaders that can help them take the next step with their science.
If you are a founder or researcher who is interested in being featured and are working in the oncology, infectious disease, cardiovascular and metabolic disease, rare disease, or neuroscience therapeutic areas, we encourage you to apply to be a featured participant.
Specifically, we plan to highlight founders and researchers:

From traditionally under-represented backgrounds in the industry – including people of color, women, the LGBTQIA+ community, and people with disabilities
Who are working towards greater health equity, clinical diversity, and/or who are making an impact in underserved disease areas or diseases that adversely affect underrepresented communities

We will feature just five companies or researchers each day of the week (Monday, Dec 5, 2022: Oncology, Tuesday, Dec 6 2022: Infectious Diseases (specifically, AMR), Wednesday, Dec 7, 2022: Cardiovascular and metabolic diseases and Rare Diseases, Thursday, Dec 8, 2022: Neuroscience). Each founder will have 20 minutes to present, with 5 minutes of audience Q&A following their presentation; presentations will happen live and via Zoom webinar each afternoon EST.

Featured speakers include Dr. Erin Duffy, Chief of Research & Development of CARB-X

Infection 2022: BSAC Winter Conference, Nouveau Frontiers in Infection: This time its personal!
2022-12-13 08:00 - 17:00 (America/New_York) | Royal College of Physicians, London

CARB-X Funding Rounds Q&A #1
2023-01-19 08:00 - 09:00 (America/New_York)
Register for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds: Webinar Registration – Zoom

Clinical Workshop on Small Molecules and Biologicals
2023-01-19 15:00 - 17:00, 2023-01-26 15:00 - 17:00, 2023-02-02 15:00 - 17:00 (Europe/Berlin)
The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one, therefore knowledge of the first part or other workshops of this series is not required.

The workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies, ethics committee, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct.

The workshop will be held as a weekly webinar over the course of three weeks with the following topics:

Session 1: Introduction on clinical development
Thursday 19th January 2023, start at 3 pm (CET)
Session 2: Role of ethics committee and supporting infrastructures
Thursday 26th January 2023, start at 3 pm (CET)
Session 3: Regulatory background of clinical studies
Thursday 2nd February 2023, start at 3 pm (CET)

For further information, please see the agenda attached.

For registration, please contact OSRA@PEI.de until 12th of January 2023 including if you are affiliated with DZIF or CARB-X.

CARB-X Funding Rounds Q&A #2
2023-01-20 19:00 - 20:00 (America/New_York)
Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds

ANTIMICROBIAL CHEMOTHERAPY CONFERENCE (ACC 2023)
2023-02-01 08:00 - 2023-02-02 17:00 (America/New_York)
This virtual conference is jointly organised by BSAC and GARDP. For ACC2023, the collaborating organisations are Africa CDC and ReAct Africa.

2023 UNIVERSAL HEALTH COVERAGE (UHC) IN AN ERA OF ANTIMICROBIAL RESISTANCE (AMR) AND PANDEMICS CONFERENCE
2023-02-21 08:00 - 2023-02-22 17:00 (America/New_York) | Tokyo Station Hotel
Built upon the outcomes of the 2018 High-level Meeting spearheaded by ASEF, the high-level conference on “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” is co-organised by Asia-Europe Foundation (ASEF), AMR Clinical Reference Center and the Ministry of Foreign Affairs of Japan. The conference will take place on 21-22 February 2023 in Tokyo, Japan.
The overall aim of this conference is to facilitate a much-needed dialogue between governments and other stakeholders on practical ways to integrate a concern for AMR into UHC. Unlike short-term measures and funding schemes, health systems are here to stay. Accordingly, the conference will discuss sustainable actions on AMR using the health system approach. Actionable AMR strategies that address the need to support high quality science and provide incentives to develop and produce new antimicrobials will also be considered. The conference will explore the links between mitigating AMR under UHC and pandemic preparedness. Last but not least, possible international collaborations and effective coordination mechanisms will also be sought, as AMR cannot be solved by a single country on its own.
The conference will bring together senior-level health officials who are working in the areas of UHC, AMR, and Pandemic Preparedness and Response (PPR). The conference will feature presentations and panel discussions on topical subjects, such as about innovative ideas on R&D and commercialisation of antimicrobials for sustainability, as well as group discussions on priorities for international cooperation between Asia and Europe to support progress towards sustainable UHC while containing risks of emerging infectious diseases, including AMR.
To learn more about the conference background, its audience, partners, and other details, please click here.
This high-level conference is an invitation-only event.

Webinar: Addressing Antimicrobial Resistance Through the Pandemic Instrument
2023-02-21 10:30 - 11:30 (America/New_York)
This moment provides an important opportunity for addressing the global threat of antimicrobial resistance (AMR).
This month, the Intergovernmental Negotiating Body (INB) –– the entity established by the World Health Organization (WHO) to draft and negotiate a pandemic instrument –– will meet to consider and negotiate the zero draft of the WHO international instrument on pandemic prevention, preparedness and response. This webinar will contribute to discussions on the pandemic instrument and the opportunity to comprehensively address the full range of pandemic threats, including AMR. AMR already kills over 1 million people annually and contributes to millions more deaths around the world – a toll that is disproportionately borne by LMICs.
Join us for a discussion and exchange inspired by the forthcoming Symposium Issue of the Journal of Law, Medicine & Ethics (JLME) on Addressing Antimicrobial Resistance through the Pandemic Instrument, guest edited by Kevin Outtersen (Boston University, CARB-X) and Global Strategy Lab’s Susan Rogers Van Katwyk and Steven J. Hoffman. The webinar will feature a roundtable format, a panel of researchers and experts on AMR policy and will be followed by a Q&A session with the audience.

BIOCOM 2023
2023-02-28 08:00 - 2023-03-02 17:00 (America/New_York)
The Premier Partnering Event of the Year
This conference is an exclusive global partnering forum that brings together senior executives, bankers, venture capitalists, and business development professionals from leading pharmaceutical and biotech companies. Join us next February 2023, where industry leaders will debate current trends, companies will showcase their latest technologies and all attendees will have the opportunity to schedule one-on-one meetings with leading deal-makers from around the globe.
